1. Transplant Options for Patients With Diabetes and Advanced Kidney Disease: A Review
- Author
-
Eelco J.P. de Koning, Martha Pavlakis, Marie-Christine Vantyghem, Aleksandra Kukla, Michael R. Rickels, Pedro Ventura-Aguiar, D J. Han, Didier A. Mandelbrot, David Goodman, Titus Augustine, Paul Johnson, Frantisek Saudek, and Matthew Cooper
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,030232 urology & nephrology ,Renal function ,Global Health ,Article ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Diabetes mellitus ,Living Donors ,medicine ,Humans ,Transplantation, Homologous ,030212 general & internal medicine ,Intensive care medicine ,Dialysis ,Kidney transplantation ,Glycemic ,business.industry ,Graft Survival ,Transplant Waiting List ,medicine.disease ,Kidney Transplantation ,Transplantation ,Diabetes Mellitus, Type 1 ,surgical procedures, operative ,Nephrology ,Kidney Diseases ,Morbidity ,business ,Kidney disease - Abstract
Optimal glycemic control in kidney transplant recipients with diabetes is associated with improved morbidity and better patient and allograft survival. Transplant options for patients with diabetes requiring insulin therapy and chronic kidney disease who are suitable candidates for kidney transplantation should include consideration of beta-cell replacement therapy: pancreas or islet transplantation. International variation related to national regulatory policies exists in offering one or both options to suitable candidates and is further affected by pancreas/islet allocation policies and transplant waiting list dynamics. The selection of appropriate candidates depends on patient age, coexistent morbidities, the timing of referral to the transplant center (predialysis versus on dialysis) and availability of living kidney donors. Therefore, early referral (estimated glomerular filtration rate < 30 mL/min/1.73 m(2)) is of the utmost importance to ensure adequate time for informed decision making and thorough pretransplant evaluation. Obesity, cardiovascular disease, peripheral vascular disease, smoking, and frailty are some of the conditions that need to be addressed before acceptance on the transplant list, and ideally before dialysis becoming imminent. This review offers insights into selection of pancreas/islet transplant candidates by transplant centers and an update on posttransplant outcomes, which may have practice implications for referring nephrologists.
- Published
- 2021
- Full Text
- View/download PDF